Skip to main content
Laurus Labs Limited logo

Laurus Labs Limited — Investor Relations & Filings

Ticker · LAURUSLABS ISIN · INE947Q01028 LEI · 335800S8HO8QRYP3VQ26 BSE.NS Manufacturing
Filings indexed 707 across all filing types
Latest filing 2022-07-19 Regulatory Filings
Country IN India
Listing BSE.NS LAURUSLABS

About Laurus Labs Limited

https://www.lauruslabs.com/

Laurus Labs Limited is a research-driven organization focused on the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDF), and specialized synthesis services. The company operates across several key therapeutic areas, including anti-retroviral (ARV), oncology, cardiovascular, and anti-diabetic treatments. Through its contract development and manufacturing organization (CDMO) division, it provides integrated drug development solutions to global partners. The company also maintains a biotechnology segment dedicated to recombinant products. Leveraging advanced research and development capabilities alongside large-scale manufacturing infrastructure, the firm emphasizes process chemistry innovation and cost-efficient production to serve diverse global healthcare markets.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial results
Regulatory Filings Classification · 100% confidence The document text is extremely short (59 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or announcement text. Given the lack of any meaningful information, the document cannot be classified as a report or announcement. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other categories.
2022-07-19 English
General updates
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming that no requests for dematerialization of securities were received during the quarter ended June 30, 2022. It is addressed to stock exchanges and regulatory bodies and is a compliance confirmation rather than a financial report or announcement of financial results. The document length is short (2447 characters) and it serves as a regulatory compliance certificate. It does not contain financial statements, management discussion, or any report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance documents and certifications that do not fit other specific categories.
2022-07-08 English
Annual General Meeting
Regulatory Filings
2022-06-30 English
Annual General Meeting
Regulatory Filings
2022-06-30 English
General updates
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to stock exchanges (BSE and NSE) regarding the vesting schedule of options granted, specifying dates and percentages for vesting over a period of years. It does not contain financial statements, audit information, or detailed report content. It is not an announcement of voting results, nor a management or board change notice. The content relates to share-based compensation but is not a remuneration report itself. Given the short length and nature of the content, it is best classified as a Regulatory Filing (RNS), which serves as a general announcement to the exchanges that does not fit other specific categories.
2022-06-30 English
Closure of trading window
Regulatory Filings Classification · 95% confidence The document text is extremely short (113 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, report content, or detailed information. Given the lack of content, this cannot be classified as a full report or detailed filing. It is most consistent with a Regulatory Filing (RNS) as a fallback category for miscellaneous or insufficient content documents.
2022-06-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.